Purchases and Sales Made in Q3 2022 in Achilles Therapeutics PLC (ACHL)
This table provides information about the institutional ownership of Achilles Therapeutics PLC (ACHL) during Q3 2022. The information is specifically focused on institutions that hold shares of Achilles Therapeutics plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
BUY
|
- |
331K+ 18.62% |
$748K - $1.12M
|
2.11M
$2.44M
|
|
|
Nov 10, 2022
Q3 2022
|
Kettle Hill Capital Management, LLC
New York, NY |
BUY
|
- |
131K+ 53.74% |
$295K - $441K
|
374K
$433K
|
|
|
Nov 14, 2022
Q3 2022
|
Forefront Analytics, LLC
West Conshohocken, PA |
BUY
|
- |
32.2KNew |
$72.8K - $109K
|
32.2K
$37.4K
|
|
|
Nov 14, 2022
Q3 2022
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
17.1KNew |
$38.6K - $57.7K
|
17.1K
$19.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Sei Investments CO
Oaks, PA |
BUY
|
- |
15.5K+ 65.59% |
$34.9K - $52.2K
|
39K
$45.3K
|
|
|
Feb 14, 2023
Q3 2022
|
Axa S.A.
Paris, I0 |
BUY
|
- |
2.2K+ 0.78% |
$4.97K - $7.44K
|
286K
$332K
|
|
|
Nov 14, 2022
Q3 2022
|
Axa S.A.
Paris, I0 |
BUY
|
- |
2.2K+ 0.78% |
$4.97K - $7.44K
|
286K
$332K
|
|
|
Nov 14, 2022
Q3 2022
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
1.27KNew |
$2.87K - $4.29K
|
1.27K
$1.47K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
819+ 12.93% |
$1.85K - $2.77K
|
7.16K
$8.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
815+ 52.18% |
$1.84K - $2.75K
|
2.38K
$2.76K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
785+ 3738.1% |
$1.77K - $2.65K
|
806
$935
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
458+ 20.83% |
$1.04K - $1.55K
|
2.66K
$3.08K
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
- |
400+ 58.39% |
$904 - $1.35K
|
1.09K
$1.26K
|
|
|
Oct 21, 2022
Q3 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
366New |
$827 - $1.24K
|
366
$425
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
140New |
$316 - $473
|
140
$162
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-12- 1.83% |
$27.1 - $40.6
|
642
$745
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-82- 0.62% |
$185 - $277
|
13.2K
$15.4K
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-82- 0.62% |
$185 - $277
|
13.2K
$15.4K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-2.76K- 22.43% |
$6.24K - $9.34K
|
9.56K
$11.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-6.2K- 7.11% |
$14K - $21K
|
81K
$94K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-7.29K- 2.8% |
$16.5K - $24.6K
|
253K
$294K
|
|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-122K- 7.67% |
$275K - $411K
|
1.46M
$1.7M
|